Robert Scott Mcdowell - Net Worth and Insider Trading
Robert Scott Mcdowell Net Worth
The estimated net worth of Robert Scott Mcdowell is at least $1 Million dollars as of 2024-09-20. Robert Scott Mcdowell is the Chief Scientific Officer of MyoKardia Inc and owns about 5,383 shares of MyoKardia Inc (MYOK) stock worth over $1 Million. Details can be seen in Robert Scott Mcdowell's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert Scott Mcdowell has not made any transactions after 2020-01-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Robert Scott Mcdowell
Robert Scott Mcdowell Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert Scott Mcdowell owns 3 companies in total, including MyoKardia Inc (MYOK) , Sunesis Pharmaceuticals Inc (SNSS) , and Viracta Therapeutics Inc (VIRX) .
Click here to see the complete history of Robert Scott Mcdowell’s form 4 insider trades.
Insider Ownership Summary of Robert Scott Mcdowell
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MYOK | MyoKardia Inc | 2020-02-14 | Chief Scientific Officer |
| SNSS | Sunesis Pharmaceuticals Inc | 2007-09-13 | Vice President & Research |
| VIRX | Viracta Therapeutics Inc | 2007-09-11 | Vice President & Research |
Robert Scott Mcdowell Latest Holdings Summary
Robert Scott Mcdowell currently owns a total of 1 stock. Robert Scott Mcdowell owns 5,383 shares of MyoKardia Inc (MYOK) as of January 6, 2020, with a value of $1 Million.
Latest Holdings of Robert Scott Mcdowell
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MYOK | MyoKardia Inc | 2020-01-06 | 5,383 | 224.91 | 1,210,691 |
Holding Weightings of Robert Scott Mcdowell
Robert Scott Mcdowell Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert Scott Mcdowell has made a total of 1 transactions in MyoKardia Inc (MYOK) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in MyoKardia Inc is the sale of 2,650 shares on January 6, 2020, which brought Robert Scott Mcdowell around $181,392.
Insider Trading History of Robert Scott Mcdowell
- 1
Robert Scott Mcdowell Trading Performance
Robert Scott Mcdowell Ownership Network
Robert Scott Mcdowell Owned Company Details
What does MyoKardia Inc do?
Who are the key executives at MyoKardia Inc?
Robert Scott Mcdowell is the Chief Scientific Officer of MyoKardia Inc. Other key executives at MyoKardia Inc include director & President and CEO Anastasios Gianakakos , General Counsel Denelle J Waynick , and Chief Business Officer Jake Bauer .
MyoKardia Inc (MYOK) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of MyoKardia Inc (MYOK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MyoKardia Inc (MYOK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
MyoKardia Inc (MYOK)'s detailed insider trading history can be found in Insider Trading Tracker table.
MyoKardia Inc Insider Transactions
Robert Scott Mcdowell Mailing Address
Above is the net worth, insider trading, and ownership report for Robert Scott Mcdowell. You might contact Robert Scott Mcdowell via mailing address: C/o Myokardia, Inc., 333 Allerton Ave., South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
